Hepatic neoplasm and Weight decreased

Summary:

Weight decreased is found among people with Hepatic neoplasm, especially for people who are male, 60+ old.

The study analyzes which people have Weight decreased with Hepatic neoplasm. It is created by eHealthMe based on reports of 69 people who have Hepatic neoplasm from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hepatic neoplasm?

Hepatic neoplasm (liver tumour) is found to be associated with 496 drugs and 519 conditions by eHealthMe. Check the latest studies of Hepatic neoplasm.

What is Weight decreased?

Weight decreased is found to be associated with 3,395 drugs and 4,744 conditions by eHealthMe. Check the latest studies of Weight decreased.



On Jul, 11, 2026

69 people who have Hepatic Neoplasm and Weight Decreased are studied.

Would you have Weight decreased when you have Hepatic neoplasm?

Gender of people who have Hepatic Neoplasm and experienced Weight Decreased *:

  • female: 35.82 %
  • male: 64.18 %

Age of people who have Hepatic Neoplasm and experienced Weight Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 12 %
  • 60+: 88 %

Common co-existing conditions for these people *:

  1. Neuroendocrine Tumor: 19 people, 27.54%
  2. High Blood Pressure: 15 people, 21.74%
  3. Type 2 Diabetes: 10 people, 14.49%
  4. Benign Pancreatic Neoplasm (benign (non-cancerous) tumours of the pancreatic): 9 people, 13.04%
  5. Diabetes Mellitus Inadequate Control: 7 people, 10.14%
  6. Pain: 7 people, 10.14%
  7. Blood Pressure Abnormal: 6 people, 8.70%
  8. Thyroid Diseases: 6 people, 8.70%
  9. Liver Disorder (liver diseases): 6 people, 8.70%
  10. Depression: 5 people, 7.25%

Common drugs taken by these people *:

  1. Nexavar: 17 people, 24.64%
  2. Humalog: 10 people, 14.49%
  3. Losartan: 7 people, 10.14%
  4. Furosemide: 6 people, 8.70%
  5. Olmesartan Medoxomil: 6 people, 8.70%
  6. Repaglinide: 6 people, 8.70%
  7. Lanreotide Acetate: 6 people, 8.70%
  8. Pantoprazole: 6 people, 8.70%
  9. Aspirin: 6 people, 8.70%
  10. Amlodipine: 6 people, 8.70%

Common symptoms for these people *:

  1. Fatigue (feeling of tiredness): 29 people, 42.03%
  2. Weakness: 28 people, 40.58%
  3. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 22 people, 31.88%
  4. Malaise (a feeling of general discomfort or uneasiness): 21 people, 30.43%
  5. Nausea (feeling of having an urge to vomit): 18 people, 26.09%
  6. Abdominal Pain: 18 people, 26.09%
  7. Pain: 17 people, 24.64%
  8. Malignant Neoplasm Progression (cancer tumour came back): 17 people, 24.64%
  9. Weight Increased: 16 people, 23.19%
  10. Abdominal Distension: 16 people, 23.19%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Weight decreased?

- Check whether Weight decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Weight decreased:

All the conditions that are associated with Weight decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Weight decreased and Hepatic neoplasm, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: